432
Participants
Start Date
December 31, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Canakinumab
Canakinumab was supplied in glass vials as a lyophilized powder.
Colchicine
0.5 mg capsule orally once daily for 16 weeks.
Allopurinol
100-300 mg orally once daily for 24 weeks.
Placebo Matching Canakinumab
Subcutaneous injection.
Placebo Matching Colchicine
Capsule orally once daily for 16 weeks.
Rochester clinical Research, Rochester
Altoona Center for Clinical Research, Duncansville
Columbia Clinical Research, Columbia
Upstate Pharmaceutical Research, Greenville
Health Awareness, Jupiter
Shores Rheumatology, Saint Clair Shores
Pinnacle Medical Research, Overland Park
Dolby Research, LLC, Baton Rouge
The Family Doctors, Shreveport
Health Research of Oklahoma, PLLC, Oklahoma City
Castlerock Clinical Research Consultants, LLC, Tulsa
iMED Internal medicine, PA, San Antonio
Talbert Medical Group, Huntington Beach
East-West Medical Research institute, Honolulu
San Diego Arthritis & Osteoporosis Medical clinic, San Diego
Cotton O'Neil Clinical Research Institute, Topeka
Heartland Clinical Research, Inc., Omaha
NM Clinical Research & Osteoporosis Ct., Albuquerque
MultiSpecialty Clinical Research, Johnson City
Novartis Investigative site, Buenos Aires
Novartis Investigative Site, Córdoba
Novartis Investigative site, Rosario
Novartis Investigative Site, Gozée
Novartis Investigative site, Oostham
Novartis Investigative Site, Bacaramanga
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Bogotá
Fundación Cardiovascular de Colombia, Florida Blanca
Novartis Investigative site, Havířov
Novartis Investigative site, Ostrava
Novartis Investigative site, Pardubice
Novartis Investigative site, Uherské Hradiště
Novartis Investigative site, Zlín
Novartis Investigative Site, Bautzen
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Dresden
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Georgensgmünd
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Messkirch
Novartis Investigative Site, München
Novartis Investigative Site, Riedlhuette
Novartis Investigative Site, Schwabach
Novartis Investigative site, Guatemala City
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Eger
Novartis Investigative Site, Kistarcsa
Novartis Investigative Site, Zalaegerszeg
Novartis Investigative Site, Poznan
Novartis Investigative Site, Wroclaw
Novartis Investigative site, Coimbra
Novartis Investigative site, Lisbon
Novartis Investigative site, Ponte de Lima
Novartis Investigative Site, Chelyabinsk
Novartis Investigative site, Moscow
Novartis Investigative Site, Petrozavodsk
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Yekaterinburg
Novartis Investigative site, Singapore
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Košice
Novartis Investigative Site, Nové Zámky
Novartis Investigative Site, Piešťany
Novartis Investigative Site, Považská Bystrica
Novartis Investigative site, Trebišov
Novartis Investigative site, Cape Town
Novartis Investigative site, Panorama
Novartis Investigative site, Port Elizabeth
Novartis Investigative Site, Barakaldo
Novartis Investigative site, Madrid
Novartis Investigative site, Mérida
Novartis Investigative site, Valencia
Novartis Investigative site, Kaohsiung City
Novartis Investigative site, Taichung
Novartis Investigative site, Taipei
Baskent University Medical Faculty, Adana
Baskent University Medical Faculty, Ankara
Adnan Menderes University Medical Faculty, Aydin
Cukurova University Medical Faculty, Balcali Adana
Pamukkale University medical Faculty, Denizli Kampus
Gaziantep University Medical Faculty, Gaziantep
Dokuz Eylul University Medical Faculty, Izmir
Celal Bayar University Medical Faculty, Manisa
Gables Medicentre, Coventry
Flyde Coast Clinical Research Ltd, Lancashire
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY